|
⚲
|
| Keyboard |
| Claypoole Robert E
✚
|
|
|---|---|
| CIK # | 0002005474 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002005474] | |
| 4 | [0002005474] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Claypoole Robert E | |
| Bioventus Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bioventus Inc BVS
Class A Common Stock
|
2026-03-13 | Option exercise | 33,500 | $0.00 | |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2026-03-13 | Grant | 278,000 | $0.00 | |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2026-03-13 | Option exercise | 33,500 | $0.00 | |
|
Bioventus Inc BVS
Stock Option (Right to Buy) · derivative
|
2026-03-13 | Grant | 309,000 | $0.00 | |
|
Bioventus Inc BVS
Class A Common Stock
|
2026-03-13 | Tax withheld | 14,553 | $8.62 | 125,447 |
|
Bioventus Inc BVS
Class A Common Stock
|
2026-01-09 | Tax withheld | 41,717 | $8.03 | 334,988 |
|
Bioventus Inc BVS
Class A Common Stock
|
2026-01-09 | Option exercise | 93,750 | $0.00 | |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2026-01-09 | Option exercise | 93,750 | $0.00 | |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2025-03-14 | Grant | 134,000 | $0.00 | |
|
Bioventus Inc BVS
Stock Option (Right to Buy) · derivative
|
2025-03-14 | Grant | 153,000 | $0.00 | |
|
Bioventus Inc BVS
Class A Common Stock
|
2025-01-13 | Sell | 28,786 | $9.10 | 261,953 |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2025-01-10 | Option exercise | 93,750 | $0.00 | |
|
Bioventus Inc BVS
Class A Common Stock
|
2025-01-10 | Option exercise | 93,750 | $0.00 | |
|
Bioventus Inc BVS
Restricted Stock Units · derivative
|
2024-01-11 | Grant | 375,000 | $0.00 | |
|
Bioventus Inc BVS
Stock Option (Right to Buy) · derivative
|
2024-01-11 | Grant | 850,000 | $0.00 |